OS 06-07 COMBINING SHORT- AND LONG-TERM RISK SCORES IN PRIMARY PREVENTION OF MAJOR CARDIOVASCULAR DISEASE EVENTS IN LOW INCIDENCE POPULATIONS

2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e63-e64
Author(s):  
Giovanni Veronesi ◽  
Simona Giampaoli ◽  
Francesco Gianfagna ◽  
Luigi Palmieri ◽  
Diego Vanuzzo ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Primary Prevention ◽  
Risk Scores ◽  
Short And Long Term ◽  
Low Incidence

Our Efforts for Ideal Stroke Prevention and Treatment in Japan

Stroke ◽  
2022 ◽  
Author(s):  
Takenori Yamaguchi
Keyword(s):  
Cardiovascular Disease ◽  
Primary Prevention ◽  
Acute Treatment ◽  
Low Dose ◽  
Dual Antiplatelet Therapy ◽  
Intravenous Thrombolysis ◽  
Short Review ◽  
Prevention And Treatment ◽  
Cardiovascular Center

In the present short review for the Sherman Award, Dr Yamaguchi introduces studies at the National Cerebral and Cardiovascular Center, Osaka, which included development of intravenous thrombolysis using low-dose alteplase that was officially approved in Japan, long-term dual antiplatelet therapy using cilostazol together with aspirin or clopidogrel, and others. He also discusses efforts to ensure the passage of the “Stroke and Cardiovascular Disease Control Act,” the aims of which are better primary prevention, better acute treatment, rehabilitation, and secondary prevention of stroke for people living in Japan.

scholarly journals Risk Scores After Acute Coronary Syndrome

Angiology ◽  
2016 ◽  
Vol 68 (3) ◽  
pp. 185-188 ◽  
Author(s):  
Genovefa D. Kolovou ◽  
Niki Katsiki ◽  
Sophie Mavrogeni
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Judgment ◽  
Risk Scores ◽  
Aggressive Treatment ◽  
Future Studies ◽  
Coronary Syndrome ◽  
Short And Long Term ◽  
Coronary Events ◽  
Global Registry

Acute coronary syndrome (ACS) is associated with both short- and long-term unfavorable prognosis. Therefore, medical societies developed risk scores for predicting mortality and assessing decision-making regarding early aggressive treatment in patients presenting an ACS. The Thrombolysis In Myocardial Infarction and the Global Registry of Acute Coronary Events risk scores are the most extensively investigated scores for ACS. Clinical judgment is also important. Significant differences in aggressive treatment of ACS still exist with respect to gender, age, and ethnicity. The reasons for these discrepancies need to be further elucidated in future studies. Therefore, generalizability of stratifications and risk scores in certain populations should be performed with caution.

Sign in / Sign up

Export Citation Format

Share Document